Compound ID | 1994
Synonym(s): SB-275833 | SB275833
Class: Pleuromutilin
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Protein synthesis inhibitor. Binds to the peptidyl transferase component of the bacterial 50S ribosomal subunit, thus inhibiting peptide bond formation |
| Description: | Synthetic pleuromutilin derivative for topical use. GSK brands no longer authorised by the European Medicine Agency (EMA) and other agencies. |
| Year first mentioned: | 2005 |
| Highest development stage: | Approved by FDA in 2007 |
| Development status: | Approved |
| Reason dropped: | Discontinued/Withdrawn in US |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/6918462 |
| Guide to Pharmacology: | retapamulin |
| Citations: |
|